Finite Element Modeling and Analysis of Ventricular Septal Defect Occluders

Author(s):  
Yiming Li ◽  
Kun Sun ◽  
Chengli Song

Transcatheter closure of ventricular septal defect (VSD) has become an alternative therapy to open-chest surgery because of simple procedure, less invasion, and high safety [1–2]. The most important occluder device of the therapy is double-disc structure which occludes the VSD, with the discs of the occluder clamp the margin of VSD while the waist of the occluder supports the VSD hole (Figure 1(a)). Commercially available occluders are woven by 72 nitinol wires (Figure1(b)) and then formed by heat treatment. However, the implantation of metal occluders in perimembranous part will result in a substantial risk of complete atrioventricular block (cAVB) averaging 3.5%, because of its close proximity to the conduction system, which passes at the posterior border of defects [3]. To improve the biocompatibility, Huang [4] developed biodegradable VSD occluders (Figure 1(c)) which woven by polydioxanone (PDO) wires and can be fully absorbed within 24 weeks after implantation.

Author(s):  
Diandong Jiang ◽  
Bo Han ◽  
Lijian Zhao ◽  
Yingchun Yi ◽  
Jianjun Zhang ◽  
...  

Background In children, the practice of transcatheter closure of intracristal ventricular septal defect (icVSD) has been limited. Currently, there is a lack of comparison between device closure of perimembranous ventricular septal defect (pmVSD) and icVSD, and long‐term clinical outcomes are rare. Methods and Results This study included a total of 633 children (39 with icVSD and 594 with pmVSD), aged 18 months to 16 years, who underwent transcatheter closure of ventricular septal defect between January 2014 and December 2018. All patients were followed up until September 2020, with a median follow‐up of 46 months in the pmVSD group and 52 months in the icVSD group. The procedural success rate was 96.3% and 84.6% in pmVSD and icVSD groups, respectively ( P =0.002). The median of age, weight, procedure time, fluoroscopic time, and radiation dose were greater in the icVSD group compared with the pmVSD group. More eccentric ventricular septal defect occluders were used in the icVSD group. Most adverse events were minor without any intervention, with cardiac rhythm/conduction abnormalities being the most common. In the pmVSD group, 2 patients experienced complete atrioventricular block, with one implanting a permanent pacemaker and the other dying of cardiac arrest secondary to reversible complete atrioventricular block 40 days postprocedure. Complete left bundle‐branch block occurred in 14 patients, and 12 cases were transient. In the icVSD group, no complete atrioventricular block or death occurred, and one patient developed transient complete left bundle‐branch block. Conclusions In selected patients, transcatheter device closure of pmVSD and icVSD can be performed safely and successfully, with excellent medium‐ and long‐term results in children.


2013 ◽  
Vol 9 (3) ◽  
pp. 211-215 ◽  
Author(s):  
Stephanie L. Siehr ◽  
Frank L. Hanley ◽  
V. Mohan Reddy ◽  
Christina Y. Miyake ◽  
Anne M. Dubin

Sign in / Sign up

Export Citation Format

Share Document